|
Sep 29
|
UPDATE 2-Aid agency urges Johnson & Johnson to improve access to tuberculosis drug
|
|
Sep 29
|
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
|
|
Sep 29
|
Aid agency urges Johnson & Johnson to improve access to tuberculosis drug
|
|
Sep 29
|
Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline
|
|
Sep 29
|
Dividend Aristocrats Ranked By Yield: Top 25
|
|
Sep 28
|
3 Dividend Kings With Recession-Proof Payouts
|
|
Sep 28
|
UPDATE 3-J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
|
|
Sep 12
|
12 Best Pharma ETFs
|
|
Sep 12
|
Novartis' (NVS) Sandoz Gets Rights for Stelara Biosimilar
|
|
Sep 12
|
AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo
|
|
Sep 12
|
Bristol Myers, J&J invest in Boston biotech's $72M VC round
|
|
Sep 11
|
Doctor asks court to toss J&J lawsuit against her over cancer research
|
|
Sep 11
|
10 Best Dividend ETFs
|
|
Sep 11
|
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
|
|
Sep 11
|
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
|
|
Sep 11
|
Could This Issue Sink Johnson & Johnson's Stock Price?
|
|
Sep 11
|
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.
|
|
Sep 10
|
25 Most Biodiverse Countries in the World
|
|
Sep 10
|
Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip
|
|
Sep 9
|
Big Pharma’s Battle With the Biden Administration Could Have Legs
|